FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (I) possessing antiprogestin properties, and to a method for treating breast cancer using such compounds. In general formula (I) X is O; R1, R2, R3 and R4 is hydrogen atoms; R5 is a radical Y, Y is acetyl, C3-cycloalkyl or pyridinyl; R6 is -OH; and R7 is a radical of formula CnFmHo, where n is 3, m is 2 or 3, o is 2 or 3 and m plus o is equal to 5.
EFFECT: disclosed is a compound of formula (I) possessing antiprogestin properties.
5 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOLYL PROGESTERONE ANTAGONISTS | 2014 |
|
RU2679445C2 |
HORMONAL OR ANTI-HORMONAL STEROID COMPOUNDS, METHODS FOR THERAPEUTIC EFFECT, METHOD FOR PREPARING COMPOUNDS | 1999 |
|
RU2238943C2 |
DERIVATIVES OF 11β-BENZALDOXIME-ESTRA-4,9-DIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2137777C1 |
COMPOUNDS WITH HYDROXYCARBONYL-HALOGENALKYL BY-SIDE CHAINS | 2000 |
|
RU2247106C2 |
PROGESTERONE RECEPTOR MODULATORS | 2005 |
|
RU2381232C2 |
DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152952C2 |
PRODUCTION METHOD FOR ULIPRISTAL ACETATE AND ITS INTERMEDIATES | 2012 |
|
RU2624007C2 |
CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID-DEHYDROGENASE 1 | 2009 |
|
RU2531272C2 |
DERIVATIVES OF 11β--BENZALDOXIME-ESTRA-4,9-DIENE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130944C1 |
DERIVATIVES OF 16-HYDROXY-11-(SUBSTITUTED PHENYL)-ESTRA-4,9-DIENE, COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2187510C2 |
Authors
Dates
2017-01-19—Published
2012-07-30—Filed